Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
41
DVA Quote, Financials, Valuation and Earnings
Last price:
$111.05
Seasonality move
:
0.44%
Day range:
$111.43 - $115.27
52-week range:
$111.43 - $179.60
Dividend yield:
0%
P/E ratio:
11.81x
P/S ratio:
0.68x
P/B ratio:
95.39x
Volume:
924.2K
Avg. volume:
890.1K
1-year change:
-24.29%
Market cap:
$8.1B
Revenue:
$12.8B
EPS (TTM):
$9.71
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DVA
DaVita, Inc.
|
$3.5B | $3.19 | 6.42% | 3.22% | $144.50 |
|
EHC
Encompass Health Corp.
|
$1.5B | $1.30 | 9.64% | 10.17% | $140.33 |
|
HCSG
Healthcare Services Group, Inc.
|
$467.2M | $0.22 | 6.72% | 39.48% | $21.50 |
|
OPCH
Option Care Health, Inc.
|
$1.5B | $0.46 | 8.07% | 30.92% | $36.91 |
|
SGRY
Surgery Partners, Inc.
|
$866.5M | $0.30 | 0.25% | 31.79% | $25.45 |
|
TOI
The Oncology Institute, Inc.
|
$139.8M | -$0.10 | 39.41% | -52.63% | $6.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DVA
DaVita, Inc.
|
$114.72 | $144.50 | $8.1B | 11.81x | $0.00 | 0% | 0.68x |
|
EHC
Encompass Health Corp.
|
$107.77 | $140.33 | $10.8B | 20.37x | $0.19 | 0.67% | 1.90x |
|
HCSG
Healthcare Services Group, Inc.
|
$18.87 | $21.50 | $1.3B | 34.92x | $0.00 | 0% | 0.77x |
|
OPCH
Option Care Health, Inc.
|
$32.79 | $36.91 | $5.2B | 26.03x | $0.00 | 0% | 0.98x |
|
SGRY
Surgery Partners, Inc.
|
$15.60 | $25.45 | $2B | -- | $0.00 | 0% | 0.60x |
|
TOI
The Oncology Institute, Inc.
|
$4.13 | $6.50 | $406.3M | -- | $0.00 | 0% | 0.77x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DVA
DaVita, Inc.
|
104.69% | 0.402 | 112.65% | 1.05x |
|
EHC
Encompass Health Corp.
|
52.86% | -0.034 | 19.56% | 0.97x |
|
HCSG
Healthcare Services Group, Inc.
|
2.72% | -0.123 | 1.17% | 3.40x |
|
OPCH
Option Care Health, Inc.
|
48.44% | -0.337 | 28.71% | 0.95x |
|
SGRY
Surgery Partners, Inc.
|
69.12% | 1.038 | 83.88% | 1.34x |
|
TOI
The Oncology Institute, Inc.
|
113.45% | -0.225 | 30.41% | 1.33x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DVA
DaVita, Inc.
|
$910M | $495.6M | 7.72% | 61.87% | 14.49% | $675.5M |
|
EHC
Encompass Health Corp.
|
$299.7M | $243.6M | 12.69% | 24.34% | 16.49% | $83.7M |
|
HCSG
Healthcare Services Group, Inc.
|
$102M | $45.9M | 7.75% | 8.02% | 9.88% | $70M |
|
OPCH
Option Care Health, Inc.
|
$256.6M | $84.5M | 8.01% | 15.16% | 5.89% | $130.2M |
|
SGRY
Surgery Partners, Inc.
|
$155.8M | $133.4M | 0.32% | 0.65% | 16.24% | $63.8M |
|
TOI
The Oncology Institute, Inc.
|
$17.2M | -$8.1M | -48.97% | -9486.64% | -5.9% | -$13.2M |
DaVita, Inc. vs. Competitors
-
Which has Higher Returns DVA or EHC?
Encompass Health Corp. has a net margin of 7.02% compared to DaVita, Inc.'s net margin of 11.82%. DaVita, Inc.'s return on equity of 61.87% beat Encompass Health Corp.'s return on equity of 24.34%.
Company Gross Margin Earnings Per Share Invested Capital DVADaVita, Inc.26.61% $2.04 $14.1B EHCEncompass Health Corp.20.28% $1.24 $5.8B -
What do Analysts Say About DVA or EHC?
DaVita, Inc. has a consensus price target of $144.50, signalling upside risk potential of 25.96%. On the other hand Encompass Health Corp. has an analysts' consensus of $140.33 which suggests that it could grow by 30.22%. Given that Encompass Health Corp. has higher upside potential than DaVita, Inc., analysts believe Encompass Health Corp. is more attractive than DaVita, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DVADaVita, Inc.1 7 0 EHCEncompass Health Corp.11 0 0 -
Is DVA or EHC More Risky?
DaVita, Inc. has a beta of 0.992, which suggesting that the stock is 0.849% less volatile than S&P 500. In comparison Encompass Health Corp. has a beta of 0.756, suggesting its less volatile than the S&P 500 by 24.396%.
-
Which is a Better Dividend Stock DVA or EHC?
DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health Corp. offers a yield of 0.67% to investors and pays a quarterly dividend of $0.19 per share. DaVita, Inc. pays -- of its earnings as a dividend. Encompass Health Corp. pays out 14.35% of its earnings as a dividend. Encompass Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DVA or EHC?
DaVita, Inc. quarterly revenues are $3.4B, which are larger than Encompass Health Corp. quarterly revenues of $1.5B. DaVita, Inc.'s net income of $240.2M is higher than Encompass Health Corp.'s net income of $174.7M. Notably, DaVita, Inc.'s price-to-earnings ratio is 11.81x while Encompass Health Corp.'s PE ratio is 20.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.68x versus 1.90x for Encompass Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DVADaVita, Inc.0.68x 11.81x $3.4B $240.2M EHCEncompass Health Corp.1.90x 20.37x $1.5B $174.7M
-
Which has Higher Returns DVA or HCSG?
Healthcare Services Group, Inc. has a net margin of 7.02% compared to DaVita, Inc.'s net margin of 9.25%. DaVita, Inc.'s return on equity of 61.87% beat Healthcare Services Group, Inc.'s return on equity of 8.02%.
Company Gross Margin Earnings Per Share Invested Capital DVADaVita, Inc.26.61% $2.04 $14.1B HCSGHealthcare Services Group, Inc.21.98% $0.59 $509.9M -
What do Analysts Say About DVA or HCSG?
DaVita, Inc. has a consensus price target of $144.50, signalling upside risk potential of 25.96%. On the other hand Healthcare Services Group, Inc. has an analysts' consensus of $21.50 which suggests that it could grow by 13.94%. Given that DaVita, Inc. has higher upside potential than Healthcare Services Group, Inc., analysts believe DaVita, Inc. is more attractive than Healthcare Services Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DVADaVita, Inc.1 7 0 HCSGHealthcare Services Group, Inc.2 3 0 -
Is DVA or HCSG More Risky?
DaVita, Inc. has a beta of 0.992, which suggesting that the stock is 0.849% less volatile than S&P 500. In comparison Healthcare Services Group, Inc. has a beta of 0.712, suggesting its less volatile than the S&P 500 by 28.833%.
-
Which is a Better Dividend Stock DVA or HCSG?
DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthcare Services Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. Healthcare Services Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DVA or HCSG?
DaVita, Inc. quarterly revenues are $3.4B, which are larger than Healthcare Services Group, Inc. quarterly revenues of $464.3M. DaVita, Inc.'s net income of $240.2M is higher than Healthcare Services Group, Inc.'s net income of $43M. Notably, DaVita, Inc.'s price-to-earnings ratio is 11.81x while Healthcare Services Group, Inc.'s PE ratio is 34.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.68x versus 0.77x for Healthcare Services Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DVADaVita, Inc.0.68x 11.81x $3.4B $240.2M HCSGHealthcare Services Group, Inc.0.77x 34.92x $464.3M $43M
-
Which has Higher Returns DVA or OPCH?
Option Care Health, Inc. has a net margin of 7.02% compared to DaVita, Inc.'s net margin of 3.61%. DaVita, Inc.'s return on equity of 61.87% beat Option Care Health, Inc.'s return on equity of 15.16%.
Company Gross Margin Earnings Per Share Invested Capital DVADaVita, Inc.26.61% $2.04 $14.1B OPCHOption Care Health, Inc.17.88% $0.32 $2.6B -
What do Analysts Say About DVA or OPCH?
DaVita, Inc. has a consensus price target of $144.50, signalling upside risk potential of 25.96%. On the other hand Option Care Health, Inc. has an analysts' consensus of $36.91 which suggests that it could grow by 12.56%. Given that DaVita, Inc. has higher upside potential than Option Care Health, Inc., analysts believe DaVita, Inc. is more attractive than Option Care Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DVADaVita, Inc.1 7 0 OPCHOption Care Health, Inc.7 1 0 -
Is DVA or OPCH More Risky?
DaVita, Inc. has a beta of 0.992, which suggesting that the stock is 0.849% less volatile than S&P 500. In comparison Option Care Health, Inc. has a beta of 0.804, suggesting its less volatile than the S&P 500 by 19.571%.
-
Which is a Better Dividend Stock DVA or OPCH?
DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. Option Care Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DVA or OPCH?
DaVita, Inc. quarterly revenues are $3.4B, which are larger than Option Care Health, Inc. quarterly revenues of $1.4B. DaVita, Inc.'s net income of $240.2M is higher than Option Care Health, Inc.'s net income of $51.8M. Notably, DaVita, Inc.'s price-to-earnings ratio is 11.81x while Option Care Health, Inc.'s PE ratio is 26.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.68x versus 0.98x for Option Care Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DVADaVita, Inc.0.68x 11.81x $3.4B $240.2M OPCHOption Care Health, Inc.0.98x 26.03x $1.4B $51.8M
-
Which has Higher Returns DVA or SGRY?
Surgery Partners, Inc. has a net margin of 7.02% compared to DaVita, Inc.'s net margin of 3.08%. DaVita, Inc.'s return on equity of 61.87% beat Surgery Partners, Inc.'s return on equity of 0.65%.
Company Gross Margin Earnings Per Share Invested Capital DVADaVita, Inc.26.61% $2.04 $14.1B SGRYSurgery Partners, Inc.18.97% -$0.18 $7.4B -
What do Analysts Say About DVA or SGRY?
DaVita, Inc. has a consensus price target of $144.50, signalling upside risk potential of 25.96%. On the other hand Surgery Partners, Inc. has an analysts' consensus of $25.45 which suggests that it could grow by 63.17%. Given that Surgery Partners, Inc. has higher upside potential than DaVita, Inc., analysts believe Surgery Partners, Inc. is more attractive than DaVita, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DVADaVita, Inc.1 7 0 SGRYSurgery Partners, Inc.8 3 0 -
Is DVA or SGRY More Risky?
DaVita, Inc. has a beta of 0.992, which suggesting that the stock is 0.849% less volatile than S&P 500. In comparison Surgery Partners, Inc. has a beta of 1.909, suggesting its more volatile than the S&P 500 by 90.922%.
-
Which is a Better Dividend Stock DVA or SGRY?
DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Surgery Partners, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. Surgery Partners, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DVA or SGRY?
DaVita, Inc. quarterly revenues are $3.4B, which are larger than Surgery Partners, Inc. quarterly revenues of $821.5M. DaVita, Inc.'s net income of $240.2M is higher than Surgery Partners, Inc.'s net income of $25.3M. Notably, DaVita, Inc.'s price-to-earnings ratio is 11.81x while Surgery Partners, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.68x versus 0.60x for Surgery Partners, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DVADaVita, Inc.0.68x 11.81x $3.4B $240.2M SGRYSurgery Partners, Inc.0.60x -- $821.5M $25.3M
-
Which has Higher Returns DVA or TOI?
The Oncology Institute, Inc. has a net margin of 7.02% compared to DaVita, Inc.'s net margin of -10.08%. DaVita, Inc.'s return on equity of 61.87% beat The Oncology Institute, Inc.'s return on equity of -9486.64%.
Company Gross Margin Earnings Per Share Invested Capital DVADaVita, Inc.26.61% $2.04 $14.1B TOIThe Oncology Institute, Inc.12.59% -$0.14 $91.3M -
What do Analysts Say About DVA or TOI?
DaVita, Inc. has a consensus price target of $144.50, signalling upside risk potential of 25.96%. On the other hand The Oncology Institute, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 57.39%. Given that The Oncology Institute, Inc. has higher upside potential than DaVita, Inc., analysts believe The Oncology Institute, Inc. is more attractive than DaVita, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DVADaVita, Inc.1 7 0 TOIThe Oncology Institute, Inc.3 0 0 -
Is DVA or TOI More Risky?
DaVita, Inc. has a beta of 0.992, which suggesting that the stock is 0.849% less volatile than S&P 500. In comparison The Oncology Institute, Inc. has a beta of 0.151, suggesting its less volatile than the S&P 500 by 84.902%.
-
Which is a Better Dividend Stock DVA or TOI?
DaVita, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DaVita, Inc. pays -- of its earnings as a dividend. The Oncology Institute, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DVA or TOI?
DaVita, Inc. quarterly revenues are $3.4B, which are larger than The Oncology Institute, Inc. quarterly revenues of $136.6M. DaVita, Inc.'s net income of $240.2M is higher than The Oncology Institute, Inc.'s net income of -$13.8M. Notably, DaVita, Inc.'s price-to-earnings ratio is 11.81x while The Oncology Institute, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DaVita, Inc. is 0.68x versus 0.77x for The Oncology Institute, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DVADaVita, Inc.0.68x 11.81x $3.4B $240.2M TOIThe Oncology Institute, Inc.0.77x -- $136.6M -$13.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
69
RGC alert for Jan 7
Regencell Bioscience Holdings Ltd. [RGC] is up 58.95% over the past day.
Buy
69
WDC alert for Jan 7
Western Digital Corp. [WDC] is down 8.88% over the past day.
Buy
75
DRUG alert for Jan 7
Bright Minds Biosciences, Inc. [DRUG] is up 2.99% over the past day.
